Avicanna Reports Q2 2026 Financial Results

Written by

in

Gross margin improves to 57%, supported by 48% quarterly growth in proprietary product sales
QUIX™ rapid-onset portfolio prepared for Q3 launch with more than 35 commercial listings secured

Originally published via Source Article.